Elicio Therapeutics Inc Share Price (NASDAQ: ELTX)

Elicio Therapeutics Inc Stock Performance

as on October 15, 2025 at 1:27 am IST

Day's Low
Day's High
$10.4
Day's Price Range
$10.7
$10.51
1.05%
Downside
1.81%
Upside
52 Week's Low
52 Week's High
$4.05
52-Week Price Range
$12.62
$10.51
61.47%
Downside
20.08%
Upside

Elicio Therapeutics Inc share price movements today

Previous Close: $10.65
Open: $10.61
Volume: 143.0K
Day's Low - High: $10.4 - $10.7
52 Week Low - High: $4.05 - $12.62

Elicio Therapeutics Inc Historical Returns

1 Month Return: + 4.17 %
3 Month Return: + 14.25 %
1 Year Return: + 133.85 %
3 Year Return: 0 %
5 Year Return: 0 %

Elicio Therapeutics Inc Stock Fundamentals & Key Indicators

Check Elicio Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$174.0M

EPS (TTM)

-2.17

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-44.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

54700.00%

Elicio Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Elicio Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Elicio Therapeutics Inc	BUY	$174.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	226.08%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.1B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.4B	91.48%	28.99	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.1B	-2.15%	14.07	31.37%

Stock Returns calculator for Elicio Therapeutics Inc Stock including INR - Dollar returns

The Elicio Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Elicio Therapeutics Inc investment value today

Current value as on today

₹2,38,907

Returns

₹1,38,907

(+138.91%)

Returns from Elicio Therapeutics Inc Stock

₹1,34,076 (+134.08%)

Dollar Returns*

₹4,831 (+4.83%)

Analyst Recommendation on Elicio Therapeutics Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Elicio Therapeutics Inc. Average target price of $15.5

Elicio Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Elicio Therapeutics Inc.

What analysts predicted

32.19%UPSIDE

Target Price

$15.5

Current Price

$10.51

Analyzed by

8 Analysts

Target

$15.50

Elicio Therapeutics Inc target price $15.5, a slight upside of 32.19% compared to current price of $10.51. According to 8 analysts rating.

Elicio Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Elicio Therapeutics Inc Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 15, 2025 to October 15, 2025

Change:-29% versus previous 30 day period

Elicio Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	1	-	-
Gross Profit	0	-	-	0	0	0	0	0	0	0
Operating Income	-7	-7	-10	-9	-10	-10	-10	-13	-10	-10
EBITDA	-7	-6	-10	-8	-11	-6	-18	-13	-10	-10
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-7	-10	-8	-11	-7	-18	-14	-11	-10
Income Tax Expense	0	0	0	0	0	-	-	0	-	-
Net Income	-8	-7	-10	-8	-11	-7	-18	-14	-11	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1201.03%	0.00%	0.00%

Elicio Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2012	Dec 2013	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	7	6	4	1	2	28	-	-	-
Gross Profit	3	3	3	0	1	27	-1	-1	-1
Operating Income	0	0	-14	-12	-15	-25	-23	-35	-44
EBITDA	1	0	-14	-40	-15	-51	-23	-32	-50
Interest Expense	0	0	-	-	8	0	3	1	0
Depreciation	-	-	-	0	0	0	0	1	1
Income Before Tax	1	1	-20	-12	-15	-26	-28	-35	-51
Income Tax Expense	0	0	-	0	0	0	3	-	-
Net Income	0	0	-20	-12	-15	-26	-28	-35	-51
Net Profit Margin	4.21%	9.61%	-497.02%	-824.54%	-545.56%	-93.25%	0.00%	0.00%	0.00%

Elicio Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-10	-8	-11	-7	-18	-14	-11	-10
Operating Cash Flow	-9	-5	-9	-12	-8	-7	-8	-10	-8
Investing Cash Flow	0	0	-	0	0	0	0	-	-
Financing Cash Flow	21	0	7	11	0	30	0	10	11
Change in Cash	12	-5	-2	-1	-8	23	-8	0	3

Elicio Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2013	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	0	-20	-12	-15	-26	-28	-35	-51
Operating Cash Flow	1	-8	-9	-16	-23	-22	-32	-37
Investing Cash Flow	0	-	0	0	0	0	0	0
Financing Cash Flow	-1	31	6	25	19	21	38	42
Change in Cash	0	23	-3	8	-5	-1	5	5

Insights on Elicio Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ELTX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 6 months, ELTX stock has moved up by 110.8%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ELTX has outperformed top 5 stocks with highest market-cap in its industry

About Elicio Therapeutics Inc

elicio is committed to transforming the lives of patients and their families by re-engineering the body’s immune response to cancer. by combining expertise in materials science and immunology, elicio is engineering potent vaccines and immuno-therapies for an array of aggressive cancers. the elicio amphiphile platform enables precise targeting and delivery of immunogens directly to the lymphatic system, the “brain center” of the immune response, to significantly amplify and enhance the body’s own system of defenses, to defeat cancer and stop its recurrence. this substantially enhanced anti-tumor functionality and long-term protective memory could unlock the full potential of the human immune response to eliminate cancer. elicio's lead amphiphile vaccines targeting pancreatic, colorectal, and head and neck cancer will begin initial patient studies in early 2020. elicio was founded to expand and apply the ground-breaking amphiphile technology invented and developed in the labs of darrell

Organisation	Elicio Therapeutics Inc
Headquarters	451 D Street, Boston, MA, United States, 02210
CEO	Mr. Robert T. Connelly
E-voting on shares	Click here to vote

Key Management of Elicio Therapeutics Inc

Name	Title
Dr. Christopher M. Haqq M.D., Ph.D.	Executive VP, Head of Research & Development and Chief Medical Officer
Dr. Darrell J. Irvine Ph.D.	Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
Dr. Preetam Shah M.B.A., Ph.D.	Chief Strategy & Financial Officer and Treasurer
Ms. Megan C. Filoon	General Counsel, Secretary & Compliance Officer
Ms. Joy Seymour	VP & Head of Regulatory Affairs
Dr. Thian Kheoh Ph.D.	Senior Vice President of Biometrics
Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.	Founder & Independent Director
Dr. Peter DeMuth Ph.D.	Chief Scientific Officer
Mr. Robert T. Connelly	CEO, President & Director
Ms. Esther Welkowsky	Senior Vice President of Clinical Development

FAQs

What is Elicio Therapeutics Inc share price today?

Elicio Therapeutics Inc share price today is $10.51 as on October 15, 2025 at 1:27 am IST at the close of the market. Elicio Therapeutics Inc share today touched a day high of $10.7 and a low of $10.4.

What is the 52 week high and 52 week low for Elicio Therapeutics Inc share?

Elicio Therapeutics Inc share touched a 52 week high of $12.62 on September 17, 2025 and a 52 week low of $4.05 on October 30, 2024. Elicio Therapeutics Inc stock price today i.e. October 15, 2025 at 1:27 am IST is closed at $10.51,which is 16.72% down from its 52 week high and 159.51% up from its 52 week low.

What is Elicio Therapeutics Inc's market capitalisation today?

Elicio Therapeutics Inc market capitalisation is $0.00T as on October 15, 2025 at 1:27 am IST.

How to invest in Elicio Therapeutics Inc Stock (ELTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Elicio Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Elicio Therapeutics Inc Shares that will get you 0.1427 shares as per Elicio Therapeutics Inc share price of $10.51 per share as on October 15, 2025 at 1:27 am IST.

What is the minimum amount required to buy Elicio Therapeutics Inc Stock (ELTX) from India?

Indian investors can start investing in Elicio Therapeutics Inc (ELTX) shares with as little as ₹87.985 or $1 (as of October 15, 2025 at 5:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Elicio Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 15, 2025 at 5:37 pm IST). Based on Elicio Therapeutics Inc share’s latest price of $10.51 as on October 15, 2025 at 1:27 am IST, you will get 0.9515 shares of Elicio Therapeutics Inc. Learn more about fractional shares .